The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins
Open accessAbstract
OBJECTIVES: This study determined excess mortality and length of hospital stay (LOS) attributable to bloodstream infection (BSI) caused by third-generation-cephalosporin-resistant Escherichia coli in Europe. METHODS: A prospective parallel matched cohort design was used. Cohort I consisted of patients with third-generation-cephalosporin-resistant E. coli BSI (REC) and cohort II consisted of patients with third-generation-cephalosporin-susceptible E. coli BSI (SEC). Patients in both cohorts were matched for LOS before infection with patients free of the respective BSI. Thirteen European tertiary care centres participated between July 2007 and June 2008. RESULTS: Cohort I consisted of 111 REC patients and 204 controls and cohort II consisted of 1110 SEC patients and 2084 controls. REC patients had a higher mortality at 30 days (adjusted odds ratio = 4.6) and a higher hospital mortality (adjusted hazard ratio = 5.7) than their controls. LOS was increased by 8 days. For SEC patients, these figures were adjusted odds ratio = 1.9, adjusted hazard ratio = 2.0 and excess LOS = 3 days. A 2.5 times [95% confidence interval (95% CI) 0.9-6.8] increase in all-cause mortality at 30 days and a 2.9 times (95% CI 1.2-6.9) increase in mortality during entire hospital stay as well as an excess LOS of 5 days (95% CI 0.4-10.2) could be attributed to resistance to third-generation cephalosporins in E. coli BSI. CONCLUSIONS: Morbidity and mortality attributable to third-generation-cephalosporin-resistant E. coli BSI is significant. If prevailing resistance trends continue, high societal and economic costs can be expected. Better management of infections caused by resistant E. coli is becoming essential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Tutorial in biostatistics: competing risks and multi‐state models
Putter, H., Fiocco, M., & Geskus, R. B. (2007) · Statistics in Medicine · doi:10.1002/sim.2712 · Cited by 2,440
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Competing Risk Regression Models for Epidemiologic Data
Lau, B., Cole, S. R., & Gange, S. J. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp107 · Cited by 1,403
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
Resistance in Gram-Negative Bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.013 · Cited by 874
Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe
Coque, T. M., Baquero, F., & Cantón, R. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19044-en · Cited by 799
Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
Schwaber, M. J., & Carmeli, Y. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm318 · Cited by 626
Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli
Giske, C. G., Monnet, D. L., Cars, O., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01169-07 · Cited by 610
Resistance in gram-negative bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.238 · Cited by 535
Schwaber, M. J., Navon-Venezia, S., Kaye, K. S., Ben-Ami, R., Schwartz, D., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1257-1262.2006 · Cited by 416
Angulo, F. J., Nargund, V. N., & Chiller, T. C. (2004) · Journal of Veterinary Medicine, Series B · doi:10.1111/j.1439-0450.2004.00789.x · Cited by 355
Influx of Extended-Spectrum -Lactamase--Producing Enterobacteriaceae into the Hospital
Ben-Ami, R., Schwaber, M. J., Navon-Venezia, S., Schwartz, D., Giladi, M., Chmelnitsky, I., Leavitt, A., & Carmeli, Y. (2006) · Clinical Infectious Diseases · doi:10.1086/500936 · Cited by 317
Fluit, A. C., Jones, M. E., Schmitz, F.-J., Acar, J., Gupta, R., Verhoef, J., & the SENTRY Participants Group (2000) · Clinical Infectious Diseases · doi:10.1086/313710 · Cited by 312
Melzer, M., & Petersen, I. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.04.007 · Cited by 298
Human Health Hazards from Antimicrobial‐Resistant Escherichia coli of Animal Origin
Hammerum, A. M., & Heuer, O. E. (2009) · Clinical Infectious Diseases · doi:10.1086/597292 · Cited by 251
Ortega, M., Marco, F., Soriano, A., Almela, M., Martínez, J. A., Muñoz, A., & Mensa, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn514 · Cited by 211
Econometric estimation of country-specific hospital costs
Adam, T., Evans, D. B., & Murray, C. J. (2003) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-1-3 · Cited by 202
Blot, S., Vandewoude, K., De Bacquer, D., & Colardyn, F. (2002) · Clinical Infectious Diseases · doi:10.1086/340616 · Cited by 201
Rooney, P. J., O'Leary, M. C., Loughrey, A. C., McCalmont, M., Smyth, B., Donaghy, P., Badri, M., Woodford, N., Karisik, E., & Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp220 · Cited by 198
Trends among pathogens reported as causing bacteraemia in England, 2004–2008
Wilson, J., Elgohari, S., Livermore, D. M., Cookson, B., Johnson, A., Lamagni, T., Chronias, A., & Sheridan, E. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03262.x · Cited by 174
Comparing alternative models: log vs Cox proportional hazard?
Basu, A., Manning, W. G., & Mullahy, J. (2004) · Health Economics · doi:10.1002/hec.852 · Cited by 169
Effect of Healthcare-Acquired Infection on Length of Hospital Stay and Cost
Graves, N., Weinhold, D., Tong, E., Birrell, F., Doidge, S., Ramritu, P., Halton, K., Lairson, D., & Whitby, M. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/512642 · Cited by 168
Newer antibacterial drugs for a new century
Devasahayam, G., Scheld, W. M., & Hoffman, P. S. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903505092 · Cited by 155
Lesens, O., Methlin, C., Hansmann, Y., Remy, V., Martinot, M., Bergin, C. J., Meyer, P., & Christmann, D. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502156 · Cited by 154
Al‐Hasan, M. N., Lahr, B. D., Eckel-Passow, J. E., & Baddour, L. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp162 · Cited by 125
Reference Group Choice and Antibiotic Resistance Outcomes
Kaye, K. S., Engemann, J. J., Mozaffari, E., & Carmeli, Y. (2004) · Emerging infectious diseases · doi:10.3201/eid1006.020665 · Cited by 119
The Brooklyn Antibiotic Resistance Task Force (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502018 · Cited by 90
Martínez, J. A., Soto, S. M., Fàbrega, A., Almela, M., Mensa, J., Soriano, À., Marco, F., de Anta, M. T. J., & Vilà, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.4.1468-1474.2006 · Cited by 81
Bhavnani, S. M., Ambrose, P. G., Craig, W. A., Dudley, M. N., & Jones, R. N. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.09.011 · Cited by 68
Modeling the effect of time-dependent exposure on intensive care unit mortality
Wolkewitz, M., Beyersmann, J., Gastmeier, P., & Schumacher, M. C. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1423-6 · Cited by 54
Self-citationAntimicrobial resistance and patient outcomes: the hazards of adjustment.
Schwaber, M. J., & Carmeli, Y. (2006) · Critical Care · doi:10.1186/cc5019 · Cited by 51
Epidemiology and outcome of primary community-acquired bacteremia in adult patients
Ortega, M., Almela, M., Martínez, J. A., Marco, F., Soriano, À., López, J. D. S., Sánchez, M., Muñoz, A., & Mensa, J. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0304-6 · Cited by 37
Cited by
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Self-citationAntibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Antimicrobial resistance: Impacts, challenges, and future prospects
Ahmed, S. K., Hussein, S., Qurbani, K., Ibrahim, R. H., Fareeq, A., Mahmood, K. A., & Mohamed, M. G. (2024) · Journal of Medicine, Surgery, and Public Health · doi:10.1016/j.glmedi.2024.100081 · Cited by 1,213
Antimicrobial Resistance: a One Health Perspective
McEwen, S. A., & Collignon, P. J. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0009-2017 · Cited by 1,199
Tang, K. L., Caffrey, N. P., Nóbrega, D. B., Cork, S. C., Ronksley, P. E., Barkema, H. W., Polachek, A. J., Ganshorn, H., Sharma, N., Kellner, J. D., et al. (2017) · The Lancet Planetary Health · doi:10.1016/s2542-5196(17)30141-9 · Cited by 942
Metadata
- Authors
- de Kraker, M. E. A., Wolkewitz, M., Davey, P. G., Koller, W., Berger, J., Nagler, J., Icket, C., Kalenic, S., Horvatic, J., Seifert, H., Kaasch, A., Paniara, O., Argyropoulou, A., Bompola, M., Smyth, E., Skally, M., Raglio, A., Dumpis, U., Melbarde Kelmere, A., Borg, M., Xuereb, D., Ghita, M. C., Noble, M., Kolman, J., Grabljevec, S., Turner, D., Lansbury, L., & Grundmann, H.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-11-23
- Volume
- 66
- Issue
- 2
- Pages
- 398-407
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2146640185
- Cited by
- 276
- References
- 36
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.